Expert Interview
A second look at the standard of care for chronic graft-versus-host disease and the future use of ibrutinib and ruxolitinib in the pediatric population
Ticker(s): INCY, ABBV, JNJ, SNYInstitution: Stony Brook University Medical Center
- Director of Bone Marrow and Blood Stem Cell Transplantation who treats 12 patients monthly with chronic graft-versus-host disease
- Has been involved in over 300 clinical trials and has worked extensively in bone marrow transplantation
- Research interests include improving stem cell transplant outcomes, CAR T cells to treat hematologic malignancies, and the role of pro-inflammatory cytokines in cancer.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
